The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapy

F.J. Koppenhagen, L.T.N. Balemans, P.A. Steerenberg, T.M. Jagmont, W. den Otter, G. Storm

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)313-329
Number of pages17
JournalJournal of Liposome Research
Publication statusPublished - 1999


  • Farmacie/Biofarmaceutische wetenschappen (FARM)
  • Medical technology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Pharmacology

Cite this